Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Volume Guarantee High-Frequency Oscillatory Ventilation (HFOV-VG) Versus Conventional High-Frequency Oscillatory Ventilation (HFOV) on Grade 2 to 3 Bronchopulmonary Dysplasia (BPD) or Death in Preterm Infants <32 Weeks With Respiratory Distress Syndrome (RDS)

NCT07377955 is registered in ClinicalTrials.gov with Xingwang Zhu as lead sponsor.

NCT NCT07377955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07377955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Volume Guarantee High-Frequency Oscillatory Ventilation (HFOV-VG) Versus Conventional High-Frequency Oscillatory Ventilation (HFOV) on Grade 2 to 3 Bronchopulmonary Dysplasia (BPD) or Death in Preterm Infants <32 Weeks With Respiratory Distress Syndrome (RDS)
Lead sponsor
Xingwang Zhu
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
February 1, 2028
Enrollment
348 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia (bpd), respiratory distress syndrome (& [hyaline membrane disease])